Frontiers in Nutrition (Oct 2024)

Effect of vitamin C supplementation on outcomes in patients with COVID-19: a systematic review and meta-analysis

  • Wenhao Xu,
  • Wenhao Xu,
  • Peng Wang,
  • Jun Wan,
  • Yaheng Tan,
  • Yuyang Liu,
  • Qiwen Chen,
  • Yuxin Zheng,
  • Xueying Yu,
  • Sitong Fan,
  • Cuyubamba Dominguez Jorge Luis,
  • Yu Zhang

DOI
https://doi.org/10.3389/fnut.2024.1465670
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundSince the emergence of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of lives have been lost, posing formidable challenges to healthcare systems worldwide. Our study aims to conduct a meta-analysis to evaluate the efficacy of vitamin C supplementation in reducing in-hospital mortality rates and shortening the length of ICU or hospital stays among patients diagnosed with COVID-19.MethodsA comprehensive systematic review and meta-analysis was conducted, sourcing data from PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials. Our analysis focused on randomized clinical trials comparing the efficacy of vitamin C supplementation with standard care in adult COVID-19 patients.ResultsThrough meticulous examination of 11 clinical trials, our meta-analysis found that vitamin C supplementation did not reduce in-hospital mortality rates in COVID-19 patients compared to those receiving standard care (Risk Ratio [RR] = 0.85; 95% Confidence Interval [CI]: 0.62–1.17; p = 0.31). Similarly, the analysis indicated no significant difference in the length of ICU stays between both cohorts. Additionally, the occurrence of other adverse events was found to be similar across both groups treated with vitamin C supplementation and standard care (all p > 0.05).ConclusionVitamin C supplementation did not reduce in-hospital mortality or ICU stay durations in patients with COVID-19. The interpretation of these findings is limited by the small number of available studies and participants, which affects the strength of the conclusions.Clinical trial registrationIdentifier CRD42024497474.

Keywords